Skip to main content

Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris

Publication ,  Journal Article
Kambam, JR; Merrill, W; Parris, W; Alhaddad, R; Naukam, R; Stewart, J; Bender, H; Sastry, BVR
Published in: Journal of Laboratory and Clinical Medicine
1990

We measured substance P-like immunoreactivity (SPLI), β-endorphin-like immunoreactivity (BELI), acetylcholinesterase activity, and total protein content in pericardial fluid and plasma of patients with angina pectoris and patients with no angina pectoris. SPLI and BELI levels, acetylcholinesterase activity, and total protein content were determined by radioimmunoassay, a colorimetric method, and by the method of Lowry et al. (J Biol Chem 1951; 193: 265-275), respectively. In the pericardial fluid, patients with angina had SPLI, BELI, acetylcholinesterase, and total protein values of 1.69 ± 0.23 fmol/mg protein, 0.16 ± 0.13 fmol/mg protein, 0.06 ± 0.02 units, and 25.7 ± 3.2 mg/ml, respectively. Patients with no angina had SPLI, BELI, acetylcholinesterase, and total protein values of 0.93 ± 0.17 fmol/mg protein, 0.19 ± 0.10 fmol/mg protein, 0.16 ± 0.02 units, and 44.6 ± 5.3 mg/ml, respectively. SPLI levels were significantly higher (p < 0.03), and acetylcholinesterase (< 0.002) and total protein content (< 0.004) were significantly lower in the pericardial fluid of patients with angina when compared with those of patients with no angina. BELI levels were not significantly different between the two groups. In the plasma, no significant differences were found in SPLI, BELI, acetylcholinesterase, and total protein values between the two groups of patients. Patients with angina had SPLI, BELI, acetylcholinesterase, and total protein values of 0.47 ± 0.26 fmol/mg protein, 0.06 ± 0.06 fmol/mg protein, 0.29 ± 0.15 units, and 68.2 ± 8.7 mg/ml, respectively. Patients with no angina had SPLI, BELI, acetylcholinesterase, and total protein values of 0.45 ± 0.08 fmol/mg protein, 0.07 ± 0.06 fmol/mg protein, 0.26 ± 0.08 units, and 70.9 ± 13.7 mg/ml, respectively. Our results may suggest that increased SPLI levels in the pericardial fluid reflect an increase in SP levels in the heart, which may be responsible for some of the symptoms, including angina, in patients with coronary ischemia.

Duke Scholars

Published In

Journal of Laboratory and Clinical Medicine

Publication Date

1990

Volume

116

Issue

5

Start / End Page

707 / 710

Related Subject Headings

  • General Clinical Medicine
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kambam, J. R., Merrill, W., Parris, W., Alhaddad, R., Naukam, R., Stewart, J., … Sastry, B. V. R. (1990). Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris. Journal of Laboratory and Clinical Medicine, 116(5), 707–710.
Kambam, J. R., W. Merrill, W. Parris, R. Alhaddad, R. Naukam, J. Stewart, H. Bender, and B. V. R. Sastry. “Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris.” Journal of Laboratory and Clinical Medicine 116, no. 5 (1990): 707–10.
Kambam JR, Merrill W, Parris W, Alhaddad R, Naukam R, Stewart J, et al. Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris. Journal of Laboratory and Clinical Medicine. 1990;116(5):707–10.
Kambam, J. R., et al. “Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris.” Journal of Laboratory and Clinical Medicine, vol. 116, no. 5, 1990, pp. 707–10.
Kambam JR, Merrill W, Parris W, Alhaddad R, Naukam R, Stewart J, Bender H, Sastry BVR. Substance P, acetylcholinesterase, and β-endorphin levels in the plasma and pericardial fluid of patients with and without angina pectoris. Journal of Laboratory and Clinical Medicine. 1990;116(5):707–710.

Published In

Journal of Laboratory and Clinical Medicine

Publication Date

1990

Volume

116

Issue

5

Start / End Page

707 / 710

Related Subject Headings

  • General Clinical Medicine
  • 1103 Clinical Sciences